| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,120 | 1,260 | 11:49 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Eco Animal Health readies poultry vaccine market entry across the EU | 1 | Alliance News | ||
| Do | ECO Animal Health plans EU rollout for poultry vaccine | 1 | Investing.com | ||
| Do | ECO Animal Health plant EU-weite Markteinführung von Geflügelimpfstoff | 1 | Investing.com Deutsch | ||
| Do | Eco Animal Health Gp - EU launch plans for ECOVAXXIN MS | - | RNS | ||
| 22.12.25 | ECO Animal Health Announces EU Marketing Authorisation For ECOVAXXIN MS | - | RTTNews | ||
| ECO ANIMAL HEALTH Aktie jetzt für 0€ handeln | |||||
| 22.12.25 | Eco Animal Health Gp - ECOVAXXIN MS EU marketing authorisation granted | - | RNS | ||
| 18.12.25 | Eco Animal Health Gp - Exercise of Share Options by Director | - | RNS | ||
| 04.12.25 | Eco Animal Health Gp - Director/PDMR Shareholding | 2 | RNS | ||
| 01.12.25 | Eco Animal Health backs outlook amid upturn in North America and China | 1 | Alliance News | ||
| 01.12.25 | ECO Animal Health Swings To Profit In H1; Stock Up | 1 | RTTNews | ||
| 01.12.25 | Eco Animal Health Gp - Results for the six months ended 30 September 2025 | - | RNS | ||
| 20.11.25 | Eco Animal Health Gp - Replacement: Notice of Results | - | RNS | ||
| 20.11.25 | Eco Animal Health Gp - Notice of Results | - | RNS | ||
| 10.11.25 | ECO Animal Health shares surge on poultry drug milestone | 2 | Sharecast | ||
| 10.11.25 | ECO Animal Health Receives Positive Opinion From CVMP For ECOVAXXIN MS | - | RTTNews | ||
| 10.11.25 | Eco Animal Health Gp - EMA Positive Opinion Received for ECOVAXXIN MS | - | RNS | ||
| 01.10.25 | Leiter für globale Forschung und Entwicklung verlässt Eco Animal Health | 2 | Investing.com Deutsch | ||
| 01.10.25 | Eco Animal Health's head of global R&D to depart | 1 | Investing.com | ||
| 01.10.25 | Eco Animal Health Gp - Head of Global R&D | - | RNS | ||
| 25.09.25 | Eco Animal Health Gp - Result of AGM | 3 | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GENEDX | 74,20 | 0,00 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| PROCEPT BIOROBOTICS | 25,920 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,570 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,010 | +0,43 % | DAX-Check LIVE: Aixtron, CEWE, Elmos, FMC, MTU, SFC Energy im Fokus | Neue Zolldrohungen aus Washington haben den deutschen Aktienmarkt zum Wochenstart unter Druck gesetzt. Der DAX fiel 1,06 Prozent auf 24.991 Punkte und rutschte damit wieder unter die Marke von 25.000... ► Artikel lesen | |
| FRESENIUS | 48,520 | -4,45 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Der Ausblick dürfte mit leichter Enttäuschung aufgenommen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,540 | -2,01 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 24,050 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,020 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,430 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| CLEARPOINT NEURO | 9,805 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| MIMEDX | 4,880 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results | Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted... ► Artikel lesen | |
| GERRESHEIMER | 15,390 | -4,53 % | Gerresheimer Aktie: Wenn selbst ein Short Squeeze unrealistisch erscheint, was bleibt dann noch? | Was sich bei der Gerresheimer AG derzeit abspielt, hat für Aktionäre alle Merkmale eines Albtraums. Der angesehene Pharma- und Kosmetikzulieferer, einst eine solide Größe im MDAX, steckt tief in einer... ► Artikel lesen |